A Simplified Algorithm for the Diagnosis, Treatment, and Management of COPD in Routine Primary Care Practice

References

• MiravitllesM, SicrasA, CrespoC, et al. Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting. Ther Adv Respir Dis. 2013;7(3):139–150. doi:10.1177/175346581348408023653458
   PubMed Web of Science ®Google Scholar
• López-CamposJL, Abad ArranzM, Calero AcuñaC, et al. Determinants for changing the treatment of COPD: a regression analysis from a clinical audit. Int J Chron Obstruct Pulmon Dis. 2016;2(11):1171–1178. doi:10.2147/COPD.S103614
   Google Scholar
• The global initiative for chronic obstructive lung disease, 2020 global strategy for prevention, diagnosis and management of COPD. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf.
   Google Scholar
• MiravitllesM, Soler-CataluñaJJ, CalleM, et al. Spanish guidelines for management of chronic obstructive pulmonary disease (gesepoc) 2017. pharmacological treatment of stable phase. Arch Bronconeumol. 2017;53(6):324–335. doi:10.1016/j.arbres.2017.03.01828477954
   PubMed Web of Science ®Google Scholar
• CabreraC, CasanovaC, MartínY, et al. Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study. Int J Chron Obstruct Pulmon Dis. 2016;8(11):1217–1222. doi:10.2147/COPD.S100853
   Web of Science ®Google Scholar
• MiravitllesM, AnzuetoA. A new two-step algorithm for the treatment of COPD. Eur Respir J. 2017;49:1602200. doi:10.1183/13993003.02200-201628179443
   PubMed Web of Science ®Google Scholar
• WensingM, HuntinkE, van LieshoutJ, et al. Tailored implementation of evidence-based practice for patients with chronic diseases. PLoS One. 2014;9(7):e101981. doi:10.1371/journal.pone.010198125003371
   PubMed Web of Science ®Google Scholar
• LundellS, TistadM, RehnB, WiklundM, HolmnerÅ, BuildingWK. COPD care on shaky ground: a mixed methods study from Swedish primary care professional perspective. BMC Health Serv Res. 2017;17(1):467. doi:10.1186/s12913-017-2393-y28693473
   PubMed Web of Science ®Google Scholar
• HarlanderM, BarrechegurenM, TurelM, MiravitllesM. Should patients switched from d to b in the gold 2017 classification be discontinued from inhaled corticosteroids? COPD. 2017;14(5):465–468. doi:10.1080/15412555.2017.134223328745524
   PubMedGoogle Scholar
• Casas Maldonado F, Arnedillo Muñoz A, López-Campos JL, et al. Documento de recomendaciones para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica en Andalucía. [Recommendations for diagnosis and treatment of Chronic Obstructive Disease in Andalusia]. 2017. Spanish.
   Google Scholar
• CohenJS, MilesMC, DonohueJF, OharJA. Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA. Int J Chron Obstruct Pulmon Dis. 2016;15(11):785–797.
   Google Scholar
• VogelmeierC, WorthH, BuhlR, et al. “Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD. Int J Chron Obstruct Pulmon Dis. 2017;1(12):487–494. doi:10.2147/COPD.S125616
   Web of Science ®Google Scholar
• Yawn BB, Thomashaw B, Mannino DM, et al. The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide. Chronic Obstr Pulm Dis 2017;4(3):177–185. doi:10.15326/jcopdf.4.3.2017.0136
   Google Scholar
• RodrigoGJ, PriceD, AnzuetoA, et al. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2017;17(12):907–922. doi:10.2147/COPD.S130482
   Web of Science ®Google Scholar
• TariqSM, ThomasEC. Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers? Int J Chron Obstruct Pulmon Dis. 2017;23(12):1877–1882. doi:10.2147/COPD.S138006
   Web of Science ®Google Scholar
• YawnBB, ThomashawB, ManninoDM, et al. 2017 Update to the COPD foundation COPD pocket consultant guide. Chronic Obstr Pulm Dis. 2017;4(3):177–185.28848929
   PubMed Web of Science ®Google Scholar
• HanMK, QuibreraPM, CarrettaEE, et al., SPIROMICS investigators. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017;5(8):619–626. doi:10.1016/S2213-2600(17)30207-228668356
   PubMed Web of Science ®Google Scholar
• LipworthB, JabbalS. A pragmatic approach to simplify inhaler therapy for COPD. Lancet Respir Med. 2017;5(9):679–681. doi:10.1016/S2213-2600(17)30264-328693987
   PubMed Web of Science ®Google Scholar
• MiravitllesM, IzquierdoJL, EsquinasC, et al. The variability of respiratory symptoms and associated factors in COPD. Respir Med. 2017;129:165–172. doi:10.1016/j.rmed.2017.06.01728732827
   PubMed Web of Science ®Google Scholar
• NonatoNL, DíazO, NascimentoOA, DreyseJ, JardimJR, LisboaC. Behavior of quality of life (SGRQ) in COPD patients according to BODE scores. Arch Bronconeumol. 2015;51(7):315–321. doi:10.1016/j.arbres.2014.02.01725622995
   PubMed Web of Science ®Google Scholar
• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• Evaluation of appropriateness of inhaled corticosteroid (ICS) therapy in COPD and guidance on ICS withdrawal. Miguel Román-Rodríguez,  Ioanna Tsiligianni, Siân Williams. Editor: Tracey Lonergan. Funding: Self-funded by IPCRG. Date published: May 2020 (2nd edition). Available from: https://www.ipcrg.org/dth6. Accessed December 03, 2020.
   Google Scholar
• Rieger-ReyesC, García-TiradoFJ, Rubio-GalánFJ, Marín-TrigoJM. Classification of chronic obstructive pulmonary disease severity according to the new global initiative for chronic obstructive lung disease 2011 guidelines: COPD assessment test versus modified medical research council scale. Arch Bronconeumol. 2014;50(4):129–134. doi:10.1016/j.arbres.2013.09.01424268434
   PubMed Web of Science ®Google Scholar
• Linstone, Harold A., and Murray Turoff, eds. The delphi method. Reading, MA: Addison-Wesley, 1975.
   Google Scholar
• Soler-CataluñaJJ, Alcázar-NavarreteB, MiravitllesM. The concept of control of COPD in clinical practice. Int J Chron Obstruct Pulmon Dis. 2014;(9):1397–1405.25548521
   PubMed Web of Science ®Google Scholar
• TrappenburgJC, van DeventerAC, TroostersT, et al. The impact of using different symptom-based exacerbation algorithms in patients with COPD. Eur Respir J. 2011;37(5):1260–1268. doi:10.1183/09031936.0013091021177839
   PubMed Web of Science ®Google Scholar
• QaseemA, WiltTJ, WeinbergerSE, et al. American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179–191.21810710
   PubMed Web of Science ®Google Scholar
• Sulku J, Janson C, Melhus H, et al. A Cross-Sectional Study Assessing Appropriateness of Inhaled Corticosteroid Treatment in Primary and Secondary Care Patients with COPD in Sweden. Int J Chron Obstruct Pulmon Dis. 2019;14:2451–2460. doi:10.2147/COPD.S21874
   Google Scholar
• Cabrera LopezC, Casanova MacarioC, Marin TrigoJM, et al. Comparison of the 2017 and 2015 global initiative for chronic obstructive lung disease reports. impact on grouping and outcomes. Am J Respir Crit Care Med. 2018;197(4):463–469. doi:10.1164/rccm.201707-1363OC29099607
   PubMed Web of Science ®Google Scholar